2025 ЙИЛДА ЎЗБЕКИСТОН АҲОЛИСИ ОРАСИДА HELICOBACTER PYLORI ИНФЕКЦИЯСИНИНГ ТАРҚАЛИШИ
##article.subject##:
Helicobacter pylori, C14 уреаза нафас тести##article.abstract##
Ушбу мақолада 2025 йилда Тошкент ва Нукус шаҳарларида Helicobacter pylori инфекциясининг тарқалиши ҳақидаги маълумотлар келтирилган. Тадқиқотлар Тошкент шаҳридаги Республика ихтисослаштирилган терапия ва тиббий реабилитация илмий-амалий тиббиёт маркази ҳамда Нукус шаҳридаги Қорақалпоғистон Республикаси кўп тармоқли тиббиёт маркази поликлиникаларида ўтказилди. Текширув диспансеризация учун поликлиникаларга мурожаат қилган ва ҳазм қилиш тизимидан шикояти бўлмаган шахслар орасида амалга оширилди. Тадқиқот натижалари кўрсатишича, текширилган шахслар орасида Helicobacter pylori инфекциясига ижобий тест Тошкент шаҳри бўйича 71,5 фоизни ва Нукус шаҳри бўйича 75 фоизни ташкил этди. Жинсий кўрсаткичларга кўра, Helicobacter pylori инфекцияси эркакларда 64 фоиз, аёлларда эса 36 фоиз ҳолларда аниқланди. 18 ёшдан 30 ёшгача бўлган шахсларнинг 65 фоизида инфекция мавжудлиги қайд этилди.
Библиографические ссылки
Malfertheiner P., Megraud F., Rokkas T., Gisbert J.P., Liou I.-M., Schulz C., et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;0:1-39. Epub ahead. https://doi.org/10.1136/gutjnl-20223277451.
LeeYC, Chiang T H, Chou C K ,et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028.
Graham DY, Klein PD, Evans DJ Jr, et al. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet.1987;1(8543):1174-1177. doi:10.1016/s0140-6736(87)92145-3.
Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017;46(9):773-779. doi:10.1111/ apt.14319.
Nyssen O P, Vaira D, Tepes B, et al. Room for improvement in the treatment of Helicobacter pylori infection: lessons from the European Registry on H.pylori Management (Hp-EuReg). J Clin Gastroenterol. 2022;56(2):e98-e108. doi:10.1097/MCG.0000000000001482.
Federal State Statistics Service. Industry structure of gross value. Accessed 02 February, 2022. http://www.gks.ru/free_doc/new_site/vvp/vrp98-18.xlsx.
Chiang TH, Chang WJ, Chen SL, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021;70(2):243-250. doi:10.1136/gutjnl-2020-322200
Bordin D., Morozov S. , Roman H. Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real-world national multicenter trial/ Helicobacter 27(4), August 2022. DOI:10.1111/hel.12924
Ivashkin V.T., Maev I.V., Gorgun J.V., Kaliaskarova K.S., Karimov M.M., Kononov A.V., Lapina T.L., Markaryan N.A., Moldobaeva M.S., Pimanov S.I., Sheptulin A.A. Pathogenetic Treatment of Gastritis as a Basis for the Prevention of Gastric Cancer in the Countries of the Commonwealth of Independent States: Literature Review and the Resolution of a Scientific Symposium Held in Minsk, Republic of Belarus, January, 27, 2018. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(4):7-14. (In Russ.) https://doi.org/10.22416/1382-4376-2018-28-4-7-14
Karimov M.M., Zufarov P.S., Islamova Sh.Z., Sobirova G.N., Karimova D.K. Employment of respiratory C14 test with Helicobacter – associated diseases // Journal Solid State Technology, 2020. Vol. 63. Iss. 6. Р. 15284 – 15291.
Dusanova N.M., Karimov M.M., Ismailova J.A., Saatov Z.Z. Epidemiology of helicobacter associated diseases of gastrointestinal tract in Uzbekistan. The local treatment protocols. Saudi Journal of Pathology and Microbiologi(SJPM) 2018 y. 124-127p.
J. Ismailova, A. Yusupbekov, M. Karimov Distribution of genotypes helicobacter pylori in Uzbekistan // Colloquim-journal №4(15), 2018. - P. 22-24.
Karimov M. M., Karimova D. K., Sobirova G. N., Abdullayeva U. K. Evaluation of the Effectiveness of Bcf-Based Eradication Therapy in Patients with Helicobaсter Pylori // American Journal of Medicine and Medical Sciences, USA, 13(6), 2023, P.810-813. (14.00.00; №2)
